ClinicalTrials.Veeva

Menu

Effects of Running Shoe Sole Hardness on Vibration and Neuromuscular Fatigue During a Half-marathon Run on a Treadmill (FAT-VIB)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Completed

Conditions

Healthy Volunteers

Treatments

Other: "hard shoes" runners evaluation
Other: "Soft shoes" runners evaluation

Study type

Interventional

Funder types

Other

Identifiers

NCT06110637
2022-A00219-34 (Other Identifier)
21CH248

Details and patient eligibility

About

During running, each contact between the foot and the ground causes an impact. Ground reaction forces (GRF) are considered as an input into the musculoskeletal system. It involves a sudden deceleration in the lower limb packages (including muscles) which generates Soft-Tissue Vibrations (STV). The body is able to attenuate Soft-Tissue Vibrations (STV) but this capability decreases with fatigue. STV could be minimize by improving shoe midsole hardness.

Full description

Only 4 studies have studied Soft-Tissue Vibrations (STV) with a distance not exceeding 10 km and without evaluating the potential influence of the shoe. Thus, the effects of shoe midsole hardness on Soft-Tissue Vibrations (STV) and neuromuscular fatigue at the end of an intense and/or long run remains unknown.

The purpose is to compare two shoes whose only midsole hardness differs during a half-marathon on Soft-Tissue Vibrations (STV), neuromuscular fatigue and running kinetics.

Maybe the shoe ensuring a better STV damping of the medial gastrocnemius muscle would reduce neuromuscular fatigue and improve comfort.

Enrollment

20 patients

Sex

Male

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Endurance runners doing a long run of at least 20 km once a week.
  • Affiliated or beneficiaries of a social security plan.
  • Have freely given their written consent.
  • Not participating in a competition during the study period.
  • Shoe size 37 to 46

Exclusion criteria

  • Any subject who has been injured in the 3 months preceding the protocol
  • Any subject with chronic joint pathologies (e.g., repeated sprains, patellar or ligament problems) or cardiac pathologies.
  • Any subject with chronic or central neurological pathologies
  • Any subject participating at the same time in another medical interventional experiment
  • Any subject who has taken corticosteroids within 3 months (inhalation, infiltration or history of prolonged corticosteroid therapy).
  • Any subject deprived of liberty or under legal protection (guardianship, curatorship, safeguard of justice, family habilitation).
  • Any subject declaring to have taken products prohibited by the World Anti-Doping Agency

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Hard shoes runners
Experimental group
Description:
Half-marathon runners with hard shoes preceded and followed by assessment of neuromuscular fatigue.
Treatment:
Other: "hard shoes" runners evaluation
Soft shoes runners
Active Comparator group
Description:
Half-marathon runners with soft shoes preceded and followed by assessment of neuromuscular fatigue.
Treatment:
Other: "Soft shoes" runners evaluation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems